Naringin Interferes Doxorubicin-Induced Myocardial Injury by Promoting the Expression of ECHS1

MLA

Zirui Zhao, et al. “Naringin Interferes Doxorubicin-Induced Myocardial Injury by Promoting the Expression of ECHS1.” Frontiers in Pharmacology, vol. 13, Apr. 2022. EBSCOhost, https://doi.org/10.3389/fphar.2022.859755.

APA

Zirui Zhao, Shilei Yang, Yawen Deng, Liang Wang, Yifen Zhang, Zhenyu Feng, Han Li, Zhongchao Chi, Yunpeng Xie, & Deshi Dong. (2022). Naringin Interferes Doxorubicin-Induced Myocardial Injury by Promoting the Expression of ECHS1. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.859755

Chicago

Zirui Zhao, Shilei Yang, Yawen Deng, Liang Wang, Yifen Zhang, Zhenyu Feng, Han Li, Zhongchao Chi, Yunpeng Xie, and Deshi Dong. 2022. “Naringin Interferes Doxorubicin-Induced Myocardial Injury by Promoting the Expression of ECHS1.” Frontiers in Pharmacology 13 (April). doi:10.3389/fphar.2022.859755.